We use nanotechnology to maximize bioavailability, bioactivity and target organ specificity of pharmaceuticals, and apply mass spectrometry imaging to monitor dynamic interactions of drugs with their target organs, to study mechanistic pathways of diseases, and to identify novel targets for therapeutic interventions.